[Evaluation of arterial infusion chemotherapy for advanced gallbladder cancer using implantable port].
Seven patients with advanced gallbladder cancer were treated by arterial infusion chemotherapy. Five patients had unresectable tumor, and two had liver metastases after resection of primary tumor. The response rate was 42.9% (3 PR), and the 1-year survival rate was 35.7%. No severe side effect was found. We conclude that arterial infusion chemotherapy is effective for advanced gallbladder cancer, and that a more effective regimen and adjuvant therapy should be established.
Dept. of Radiology, Kochi Medical School.
Y
Y
Hata
S
S
Morita
N
N
Hisa
Y
Y
Fujiwara
T
T
Higaki
O
O
Kamiike
D
D
Yoshida
S
S
Yoshida
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D015251:Epirubicin / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D005706:Gallbladder Neoplasms / Q000188:drug therapy*; D006801:Humans; D015918:Infusion Pumps, Implantable; D007261:Infusions, Intra-Arterial; D008297:Male; D016685:Mitomycin / Q000008:administration & dosage; D016896:Treatment Outcome
D015251:Epirubicin; D016685:Mitomycin; D005472:Fluorouracil